On July 25, 2026, leading endocrinologists in Dubai and Abu Dhabi highlighted the growing demand for targeted hormonal therapies in the Middle East, along with new cold-chain logistics guidelines. Sourcing specialized treatments like Netocta LAR (Octreotide) 20mg Injection is essential for clinical stability in patients with growth hormone disorders and neuroendocrine tumors in the UAE.

At Critical Kare Pharma, we operate a fully verified GDP cold-chain transport network to deliver authentic hormonal and oncology products directly to patients and healthcare facilities across the United Arab Emirates. Direct sourcing bridges availability gaps and ensures high safety standards.

Advanced Endocrine Care with Octreotide LAR

• Acromegaly Control: Successfully manages excess growth hormone and normalizes IGF-1 levels in patients who have had inadequate responses to surgery or radiotherapy.
• Neuroendocrine Tumor Care: Suppresses severe diarrhea and flushing associated with carcinoid syndrome.
• How to Use & Administer: Administered as a monthly deep intramuscular injection in the gluteus muscle. Reconstitution of the suspension requires strict adherence to the manufacturer's clinical instructions, including letting the vial stand to reach room temperature before mixing.
• Cold Chain Distribution: Because somatostatin peptides degrade if exposed to warm climates, Critical Kare Pharmaguarantees temperature-controlled transport (2–8°C) with real-time tracking for every shipment to the UAE.

UAE MOHAP Import Sourcing Guidelines

Sourcing personal prescription medications requires alignment with the UAE Ministry of Health and Prevention (MOHAP) guidelines. Patients need a valid medical prescription from a registered endocrinologist or oncologist to clear imports. Critical Kare Pharma manages customs documentation, Certificate of Analysis (COA) checks, and temperature-controlled air freight directly to your doorstep in Dubai, Abu Dhabi, or Sharjah.